Completed NCT00458367
This study is completed. It focuses on Schizophrenia.
Location not clearly listed Schizophrenia Drug i A study involving a medication or substance. Over 18 Years
Countries
Sponsor Janssen Pharmaceutica N.V., Belgium
Condition Schizophrenia Completed NCT00313391
This summary needs review. Please check the official study record and contact the research team for details.
In Atlanta Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor Emory University
Condition Schizophrenia Completed NCT00177164
This study exists to see whether a medication treatment can make care clearer and more responsive. Researchers are trying to understand whether a medication treatment can better prevent setbacks and support longer-term stability.
Multiple locations, including Bridgeville Bipolarity Drug From 18 Years to 70 Years
Countries United States
Sponsor University of Pittsburgh
Condition Bipolarity Completed NCT01411085
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Worcester Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Dartmouth-Hitchcock Medical Center
Condition Schizophrenia Completed NCT00176202
This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.
In Chicago Bipolarity Drug From 10 Years to 20 Years
Countries United States
Sponsor University of Illinois at Chicago
Condition Bipolarity Completed NCT00167154
This summary needs review. Please check the official study record and contact the research team for details.
In Birmingham Depression, Suicidality Drug From 19 Years to 60 Years
Countries United States
Sponsor University of Alabama at Birmingham
Condition Depression, Suicidality Completed NCT00215241
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Atlanta PTSD Drug From 18 Years to 65 Years
Countries United States
Sponsor Duke University
Condition PTSD Completed NCT00297739
This summary needs review. Please check the official study record and contact the research team for details.
In Coral Gables ADHD Drug From 7 Years to 12 Years
Countries United States
Sponsor Armenteros, Jorge L., M.D., P.A.
Condition ADHD Completed NCT00289861
This summary needs review. Please check the official study record and contact the research team for details.
In Boston Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition Schizophrenia Completed NCT00158028
This summary needs review. Please check the official study record and contact the research team for details.
In The Bronx Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Icahn School of Medicine at Mount Sinai
Condition Schizophrenia Completed NCT00208182
This summary needs review. Please check the official study record and contact the research team for details.
In Omaha PTSD Drug From 19 Years to 64 Years
Countries United States
Sponsor Creighton University
Condition PTSD Completed NCT00272597
This summary needs review. Please check the official study record and contact the research team for details.
In Coquitlam Schizophrenia Drug From 18 Years to 65 Years
Countries Canada
Sponsor University of British Columbia
Condition Schizophrenia